MFS Meridian Funds - Continental European Equity Fund C1 USDRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 7.5 | 17.5 | -6.5 | 9.1 | 2.5 | |
+/-Cat | -1.9 | 2.0 | 2.2 | -4.5 | -0.1 | |
+/-B’mrk | -0.4 | 0.2 | 0.9 | -5.9 | -2.0 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 22/11/2024 | USD 16.71 | |
Day Change | 1.17% | |
Morningstar Category™ | Europe ex-UK Equity | |
ISIN | LU1123739267 | |
Fund Size (Mil) 22/11/2024 | EUR 68.91 | |
Share Class Size (Mil) 31/10/2024 | EUR 0.08 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 2.60% |
Investment Objective: MFS Meridian Funds - Continental European Equity Fund C1 USD |
The Fund’s objective is capital appreciation, measured in euros. The Fund invests primarily (at least 70%) in continental European equity securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Matthew Barrett 03/01/2009 | ||
Inception Date 05/12/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for MFS Meridian Funds - Continental European Equity Fund C1 USD | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
SAP SE | Technology | 6.26 |
Schneider Electric SE | Industrials | 5.59 |
Roche Holding AG | Healthcare | 5.27 |
Linde PLC | Basic Materials | 4.84 |
Novartis AG Registered Shares | Healthcare | 4.74 |
Increase Decrease New since last portfolio | ||
MFS Meridian Funds - Continental European Equity Fund C1 USD |